Supportive Care | Beta Thalassemia Intermedia and Minor

Home page of Medical Information for Clinicians

Home page of Medical Information for Clinicians

Medical Information for Clinicians

Select language English

BETA THALASSEMIA INTERMEDIA AND MINOR

Supportive Care

English

Supportive Care

/assets/ct/fa815d8e9f/images/syn_placeholder_sqr.png

Iron Chelation

Iron out for nontransfused thalassemia. (opens new window)

Marks PW.

Source‎: Blood 2012;120(5):928-9.

Iron overload in β-thalassemia intermedia: an emerging concern. (opens new window)

Musallam KM, Cappellini MD, Taher AT.

Source‎: Curr Opin Hematol 2013;20(3):187-92.

Dietary Supplements and Other Supportive Therapies

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (opens new window)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Source‎: Blood 2012;120(7):1531-2.

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (opens new window)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Source‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Therapeutic roles of curcumin: lessons learned from clinical trials. (opens new window)

Gupta SC, Patchva S, Aggarwal BB.

Source‎: AAPS J 2013;15(1):195-218.

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (opens new window)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Source‎: J Med Assoc Thai 2012;95(1):29-36.

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (opens new window)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Source‎: Am J Hematol 2013;88(6):503-6.

Hospital Liaison Committee (HLC)

Contact local representatives who provide free assistance to clinicians treating Jehovah’s Witnesses.

Medical Information Packets

Subjects include: Clinical strategies for managing hemorrhage and anemia without blood transfusion, the religious and ethical position of Jehovah’s Witnesses on medical therapy, and the services Witnesses offer to the medical community through their worldwide network of Hospital Liaison Committees.

Videos

Treatment options as well as medical and ethical considerations for clinicians who treat Jehovah’s Witnesses.

The medical section of this website is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.